查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1424065

支原體檢測市場、份額、規模、趨勢、產業分析報告：按產品/服務、技術、應用、最終用戶、地區、細分市場預測，2024-2032

Mycoplasma Testing Market Share, Size, Trends, Industry Analysis Report, By Product & Service (Assays, Kits, & Reagents, Instruments, Services); By Technique; By Application; By End User; By Region; Segment Forecast, 2024 - 2032
出版日期: | 出版商: Polaris Market Research | 英文 118 Pages | 商品交期: 最快1-2個工作天內

價格

根據Polaris Market Research的最新研究，預計到2032年，全球支原體檢測市場規模將達到290,964萬美元。 該報告提供了對當前市場動態的詳細見解，並對未來市場成長進行了分析。

支原體是一種沒有細胞壁的細菌。 它最有可能感染人體的呼吸、泌尿和生殖器官。 嚴格的法規和日益增長的消費者安全擔憂正促使製藥公司專注於全面的生物檢測，包括支原體檢測。

2023 年《微生物學雜誌》上發表的一項研究重點在於探討生殖支原體檢測的進展。 隨著美國食品和藥物管理局 (FDA) 最近批准基於分子的檢測，診斷測試已在美國廣泛採用，並且不再僅在少數實驗室中提供。 這對支原體市場的成長有正面影響。

抗菌藥物抗藥性的出現使得檢測藥物和服務中是否存在支原體變得困難，從而刺激了確定抗藥性的診斷測試的發展。 支原體主要在生物製藥的生產過程中從研究到臨床開發過程中檢測到，這凸顯了支原體檢測的必要性，以確認特定疾病治療的安全性和準確性。

推進該領域的研究創新和先進技術的採用預計將推動支原體檢測市場的擴大。 例如，2023 年 11 月，QIAGEN 宣布推出三款新的 QIAcuity 試劑盒和軟體更新，以擴展其在細胞和基因治療、食品業和製藥業的聚合□鏈反應技術的產品線。

生物製藥公司為提高產品品質和安全性而不斷擴張的努力正在對支原體檢測市場產生積極影響。 例如，2023 年 11 月，專門從事保護藥物免受細菌侵害的製藥實驗室 Bionique 宣布業務已擴展到紐約州克利爾湖。

支原體檢測市場報告亮點

由於對現成測試試劑盒的需求，檢測、試劑盒和試劑領域預計將在未來幾年實現最高成長。

市場區隔領域由於能夠提供快速測試結果而佔據最大的市場份額。

由於生物製藥產量的增加，細胞系測試部門預計將佔據更大的收入份額。

由於細胞和基因治療技術創新的不斷發展，預計亞太地區將在預測期內實現最快的成長。

目錄

第 1 章簡介

第 2 章執行摘要

第 3 章研究方法

第 4 章全球支原體檢測市場洞察

  • 支原體檢測 - 產業概況
  • 支原體偵測市場動態
    • 促進因素和機會
      • 探索支原體檢測的研究增加
      • 支原體相關健康問題的發生率增加
    • 抑制因素和挑戰
      • 研究者抵制採用新創新
  • PESTLE分析
  • 支原體檢測產業趨勢
  • 價值鏈分析
  • COVID-19 感染的影響分析

第 5 章全球支原體檢測市場，依產品及服務劃分

  • 主要發現
  • 簡介
  • 檢測、試劑盒及試劑
  • 設備
  • 服務

第 6 章全球支原體檢測市場（依應用）

  • 主要發現
  • 簡介
  • 細胞系測試
  • 病毒檢查
  • 生產結束後的細胞檢查

第 7 章全球支原體檢測市場（依技術）

  • 主要發現
  • 簡介
  • NAT
  • ELISA
  • 染色
  • 其他技術

第 8 章全球支原體檢測市場（依最終用戶）

  • 主要發現
  • 簡介
  • 製藥和生技公司
  • 細胞庫和研究所
  • 合約研究組織
  • 學術研究所

第 9 章全球支原體檢測市場（按地區）

  • 主要發現
  • 簡介
    • 2019-2032 年支原體檢測市場評估（按地區）
  • 支原體檢測市場－北美
    • 北美：支原體檢測市場，按產品和服務劃分，2019-2032 年
    • 北美：支原體檢測市場，依最終用戶劃分，2019-2032 年
    • 北美：支原體檢測市場，按應用劃分，2019-2032 年
    • 北美：支原體檢測市場，按技術，2019-2032 年
    • 支原體檢測市場—美國
    • 支原體檢測市場－加拿大
  • 支原體檢測市場－歐洲
    • 歐洲：支原體檢測市場，依產品與服務劃分，2019-2032 年
    • 歐洲：支原體檢測市場，依最終用戶劃分，2019-2032 年
    • 歐洲：支原體檢測市場，依應用劃分，2019-2032 年
    • 歐洲：支原體檢測市場，按技術，2019-2032 年
    • 支原體檢測市場 - 英國
    • 支原體檢測市場 - 法國
    • 支原體檢測市場 - 德國
    • 支原體檢測市場 - 義大利
    • 支原體檢測市場 - 西班牙
    • 支原體檢測市場 - 荷蘭
    • 支原體檢測市場 - 俄羅斯
  • 支原體檢測市場 - 亞太地區
    • 亞太地區：支原體檢測市場，按產品和服務劃分，2019-2032 年
    • 亞太地區：支原體檢測市場，依最終用戶劃分，2019-2032 年
    • 亞太地區：支原體檢測市場，依應用劃分，2019-2032 年
    • 亞太地區：支原體檢測市場，按技術，2019-2032 年
    • 支原體檢測市場—中國
    • 支原體檢測市場—印度
    • 支原體檢測市場 - 日本
    • 支原體檢測市場—馬來西亞
    • 支原體檢測市場 - 印尼
    • 支原體檢測市場－韓國
  • 支原體檢測市場 - 中東和非洲
    • 中東和非洲：支原體檢測市場，按產品和服務劃分，2019-2032 年
    • 中東和非洲：支原體檢測市場，按最終用戶劃分，2019-2032 年
    • 中東和非洲：支原體檢測市場，按應用劃分，2019-2032 年
    • 中東和非洲：支原體檢測市場，按技術，2019-2032 年
    • 支原體檢測市場 - 沙烏地阿拉伯
    • 支原體檢測市場—南非
    • 支原體檢測市場 - 以色列
    • 支原體偵測市場－阿聯酋
  • 支原體檢測市場－拉丁美洲
    • 拉丁美洲：支原體檢測市場，依產品與服務劃分，2019-2032 年
    • 拉丁美洲：支原體檢測市場，以最終用戶劃分，2019-2032 年
    • 拉丁美洲：支原體檢測市場，按應用劃分，2019-2032 年
    • 拉丁美洲：支原體檢測市場，1按技術，2019-2032 年
    • 支原體檢測市場 - 墨西哥
    • 支原體檢測市場 - 巴西
    • 支原體檢測市場－阿根廷

第 10 章競爭態勢

  • 擴張與收購分析
    • 擴大
    • 收購
  • 夥伴關係/協作/協議/揭露

第 11 章公司簡介

  • Agilent Technologies（US）
  • American Type Culture Collection（US）
  • Biological Industries Israel Beit Haemek Ltd.（Israel）
  • Bionique Testing Laboratories, Inc.（US）
  • Biotools B & M Labs, S.A.（Spain）
  • Charles River Laboratories International, Inc.（US）
  • Creative Bioarray（US）
  • Eurofins Scientific（Luxembourg）
  • GeneCopoeia, Inc.（US）
  • GenBio（Canada）
  • InvivoGen（US）
  • Lonza Group Ltd.（Switzerland）
  • Merck KGaA（Germany）
  • Meridian Bioscience, Inc.（US）
  • Minerva Biolabs GmbH（Germany）
Product Code: PM1785

The global mycoplasma testing market size is expected to reach USD 2909.64 Million by 2032, according to a new study by Polaris Market Research. The report "Mycoplasma Testing Market Share, Size, Trends, Industry Analysis Report, By Product & Service (Assays, Kits, & Reagents, Instruments, Services); By Technique; By Application; By End User; By Region; Segment Forecast, 2024 - 2032" gives a detailed insight into current market dynamics and provides analysis on future market growth.

Mycoplasma is a type of bacteria without a cell wall. It is mostly likely to affect the respiratory, urinary, and genital tracts of humans. The presence of stringent regulations and growing concerns about consumer safety is enabling pharmaceutical companies to focus on comprehensive biological testing, including testing of mycoplasma.

A 2023 study published in the Journal of Microbiology focused on exploring advancements in the detection of Mycoplasma genitalium. The recent clearance of molecular-based assays by the U.S. Food and Drug Administration (FDA) permitted diagnostic testing to be widely employed in the United States, making it no longer available only in some laboratories. This is positively influencing the growth of the mycoplasma market.

The emergence of antimicrobial resistance made it difficult to test the presence of mycoplasma in pharmaceutical products and services, which fueled the development of diagnostic tests to determine resistance. Mycoplasma is mostly found in the production phase of biopharmaceutical products, including from the research stage to clinical development, highlighting the need for mycoplasma testing to check safety and accuracy in treating certain diseases.

The growing research innovations in this field and the adoption of advanced technologies are anticipated to promote the expansion of the mycoplasma testing market. For instance, in November 2023, QIAGEN unveiled its three new QIAcuity kits and software update to expand its product line for polymerase chain reaction technology in cell and gene therapies, the food industry, and the pharmaceutical industry.

Ongoing expansion activities by biopharmaceutical companies to enhance the quality and safety of their products are positively influencing the mycoplasma testing market. For instance, in November 2023, Bionique, a pharmaceutical lab specializing in protecting medicines from bacteria, expanded its location at Lake Clear, New York, to meet ongoing demand from rapidly growing cell and gene therapies in the region.

Mycoplasma Testing Market Report Highlights

Assays, Kits, & reagents segment is anticipated to witness the highest growth in the coming years due to the need for ready-to-test kits.

NAT segment accounted for the largest market share owing to its capability to offer faster results.

Cell line testing segment is projected to experience a larger revenue share due to growing biopharmaceutical production.

Asia Pacific is projected to register the fastest growth during the forecast period, attributable to the rising innovations in cell and gene therapies.

The global players include Agilent Technologies, American Type Culture Collection, Biological Industries Israel Beit Haemek Ltd, & Bionique Testing Laboratories, Inc.

Polaris Market Research has segmented the mycoplasma testing market report based on product & service, technique, application, end user and region:

Mycoplasma Testing, Product & Service Outlook (Revenue - USD Million, 2019 - 2032)

  • Assays, Kits, & Reagents
  • NAT assays, kits, & reagents
  • ELISA assays, kits, & reagents
  • Elimination Kits
  • Stains
  • Other assays, kits, & reagents
  • Instruments
  • Services

Mycoplasma Testing, Technique Outlook (Revenue - USD Million, 2019 - 2032)

  • NAT
  • ELISA
  • Staining
  • Other technique

Mycoplasma Testing, Application Outlook (Revenue - USD Million, 2019 - 2032)

  • Cell line testing
  • Virus Testing
  • End-of-Production cell testing

Mycoplasma Testing, End User Outlook (Revenue - USD Million, 2019 - 2032)

  • Pharmaceutical & Biotechnology Companies
  • Cell Banks & Laboratories
  • Contract Research Organizations
  • Academic Research Institutes

Mycoplasma Testing, Regional Outlook (Revenue - USD Million, 2019 - 2032)

  • North America
  • U.S.
  • Canada
  • Europe
  • Germany
  • UK
  • France
  • Italy
  • Spain
  • Russia
  • Netherlands
  • Asia Pacific
  • China
  • India
  • Japan
  • South Korea
  • Indonesia
  • Malaysia
  • Latin America
  • Argentina
  • Brazil
  • Mexico
  • Middle East & Africa
  • UAE
  • Saudi Arabia
  • Israel
  • South Africa

Table of Contents

1. Introduction

  • 1.1. Report Description
    • 1.1.1. Objectives of the Study
    • 1.1.2. Market Scope
    • 1.1.3. Assumptions
  • 1.2. Stakeholders

2. Executive Summary

  • 2.1. Market Highlights

3. Research Methodology

  • 3.1. Overview
    • 3.1.1. Data Mining
  • 3.2. Data Sources
    • 3.2.1. Primary Sources
    • 3.2.2. Secondary Sources

4. Global Mycoplasma Testing Market Insights

  • 4.1. Mycoplasma Testing - Industry Snapshot
  • 4.2. Mycoplasma Testing Market Dynamics
    • 4.2.1. Drivers and Opportunities
      • 4.2.1.1. Rising research studies exploring mycoplasma detection
      • 4.2.1.2. The growing incidence of mycoplasma-related health issues
    • 4.2.2. Restraints and Challenges
      • 4.2.2.1. The researchers' resistance in adopting new innovations
  • 4.3. Porter's Five Forces Analysis
    • 4.3.1. Bargaining Power of Suppliers (Moderate)
    • 4.3.2. Threats of New Entrants: (Low)
    • 4.3.3. Bargaining Power of Buyers (Moderate)
    • 4.3.4. Threat of Substitute (Moderate)
    • 4.3.5. Rivalry among existing firms (High)
  • 4.4. PESTLE Analysis
  • 4.5. Mycoplasma Testing Industry Trends
  • 4.6. Value Chain Analysis
  • 4.7. COVID-19 Impact Analysis

5. Global Mycoplasma Testing Market, by Product & Service

  • 5.1. Key Findings
  • 5.2. Introduction
    • 5.2.1. Global Mycoplasma Testing Market, by Product & Service, 2019-2032 (USD Million)
  • 5.3. Assays, Kits, & Reagents
    • 5.3.1. Global Mycoplasma Testing Market, by Assays, Kits, & Reagents, by Region, 2019-2032 (USD Million)
    • 5.3.2. NAT assays, kits, & reagents
      • 5.3.2.1. Global Mycoplasma Testing Market, by NAT assays, kits, & reagents, by Region, 2019-2032 (USD Million)
    • 5.3.3. ELISA assays, kits, & reagents
      • 5.3.3.1. Global Mycoplasma Testing Market, by ELISA assays, kits, & reagents, by Region, 2019-2032 (USD Million)
    • 5.3.4. Elimination Kits
      • 5.3.4.1. Global Mycoplasma Testing Market, by Elimination Kits, by Region, 2019-2032 (USD Million)
    • 5.3.5. Stains
      • 5.3.5.1. Global Mycoplasma Testing Market, by Stains, by Region, 2019-2032 (USD Million)
    • 5.3.6. Other assays, kits, & reagents
      • 5.3.6.1. Global Mycoplasma Testing Market, by Other assays, kits, & reagents, by Region, 2019-2032 (USD Million)
  • 5.4. Instruments
    • 5.4.1. Global Mycoplasma Testing Market, by Instruments, by Region, 2019-2032 (USD Million)
  • 5.5. Services
    • 5.5.1. Global Mycoplasma Testing Market, by Services, by Region, 2019-2032 (USD Million)

6. Global Mycoplasma Testing Market, by Application

  • 6.1. Key Findings
  • 6.2. Introduction
    • 6.2.1. Global Mycoplasma Testing Market, by Application, 2019-2032 (USD Million)
  • 6.3. Cell line testing
    • 6.3.1. Global Mycoplasma Testing Market, by Cell line testing, by Region, 2019-2032 (USD Million)
  • 6.4. Virus Testing
    • 6.4.1. Global Mycoplasma Testing Market, by Virus Testing, by Region, 2019-2032 (USD Million)
  • 6.5. End-of-Production cell testing
    • 6.5.1. Global Mycoplasma Testing Market, by End-of-Production cell testing, by Region, 2019-2032 (USD Million)

7. Global Mycoplasma Testing Market, by Technique

  • 7.1. Key Findings
  • 7.2. Introduction
    • 7.2.1. Global Mycoplasma Testing Market, by Technique, 2019-2032 (USD Million)
  • 7.3. NAT
    • 7.3.1. Global Mycoplasma Testing Market, by NAT, by Region, 2019-2032 (USD Million)
  • 7.4. ELISA
    • 7.4.1. Global Mycoplasma Testing Market, by ELISA, by Region, 2019-2032 (USD Million)
  • 7.5. Staining
    • 7.5.1. Global Mycoplasma Testing Market, by Staining, by Region, 2019-2032 (USD Million)
  • 7.6. Other technique
    • 7.6.1. Global Mycoplasma Testing Market, by Other technique, by Region, 2019-2032 (USD Million)

8. Global Mycoplasma Testing Market, by End User

  • 8.1. Key Findings
  • 8.2. Introduction
    • 8.2.1. Global Mycoplasma Testing Market, by End User, 2019-2032 (USD Million)
  • 8.3. Pharmaceutical & Biotechnology Companies
    • 8.3.1. Global Mycoplasma Testing Market, by Pharmaceutical & Biotechnology Companies, by Region, 2019-2032 (USD Million)
  • 8.4. Cell Banks & Laboratories
    • 8.4.1. Global Mycoplasma Testing Market, by Cell Banks & Laboratories, by Region, 2019-2032 (USD Million)
  • 8.5. Contract Research Organizations
    • 8.5.1. Global Mycoplasma Testing Market, by Contract Research Organizations, by Region, 2019-2032 (USD Million)
  • 8.6. Academic Research Institutes
    • 8.6.1. Global Mycoplasma Testing Market, by Academic Research Institutes, by Region, 2019-2032 (USD Million)

9. Global Mycoplasma Testing Market, by Geography

  • 9.1. Key findings
  • 9.2. Introduction
    • 9.2.1. Mycoplasma Testing Market Assessment, By Geography, 2019-2032 (USD Million)
  • 9.3. Mycoplasma Testing Market - North America
    • 9.3.1. North America: Mycoplasma Testing Market, by Product & Service, 2019-2032 (USD Million)
    • 9.3.2. North America: Mycoplasma Testing Market, by End User, 2019-2032 (USD Million)
    • 9.3.3. North America: Mycoplasma Testing Market, by Application, 2019-2032 (USD Million)
    • 9.3.4. North America: Mycoplasma Testing Market, by Technique, 2019-2032 (USD Million)
    • 9.3.5. Mycoplasma Testing Market - U.S.
      • 9.3.5.1. U.S.: Mycoplasma Testing Market, by Product & Service, 2019-2032 (USD Million)
      • 9.3.5.2. U.S.: Mycoplasma Testing Market, by End User, 2019-2032 (USD Million)
      • 9.3.5.3. U.S.: Mycoplasma Testing Market, by Application, 2019-2032 (USD Million)
      • 9.3.5.4. U.S.: Mycoplasma Testing Market, by Technique, 2019-2032 (USD Million)
    • 9.3.6. Mycoplasma Testing Market - Canada
      • 9.3.6.1. Canada: Mycoplasma Testing Market, by Product & Service, 2019-2032 (USD Million)
      • 9.3.6.2. Canada: Mycoplasma Testing Market, by End User, 2019-2032 (USD Million)
      • 9.3.6.3. Canada: Mycoplasma Testing Market, by Application, 2019-2032 (USD Million)
      • 9.3.6.4. Canada: Mycoplasma Testing Market, by Technique, 2019-2032 (USD Million)
  • 9.4. Mycoplasma Testing Market - Europe
    • 9.4.1. Europe: Mycoplasma Testing Market, by Product & Service, 2019-2032 (USD Million)
    • 9.4.2. Europe: Mycoplasma Testing Market, by End User, 2019-2032 (USD Million)
    • 9.4.3. Europe: Mycoplasma Testing Market, by Application, 2019-2032 (USD Million)
    • 9.4.4. Europe: Mycoplasma Testing Market, by Technique, 2019-2032 (USD Million)
    • 9.4.5. Mycoplasma Testing Market - UK
      • 9.4.5.1. UK: Mycoplasma Testing Market, by Product & Service, 2019-2032 (USD Million)
      • 9.4.5.2. UK: Mycoplasma Testing Market, by End User, 2019-2032 (USD Million)
      • 9.4.5.3. UK: Mycoplasma Testing Market, by Application, 2019-2032 (USD Million)
      • 9.4.5.4. UK: Mycoplasma Testing Market, by Technique, 2019-2032 (USD Million)
    • 9.4.6. Mycoplasma Testing Market - France
      • 9.4.6.1. France: Mycoplasma Testing Market, by Product & Service, 2019-2032 (USD Million)
      • 9.4.6.2. France: Mycoplasma Testing Market, by End User, 2019-2032 (USD Million)
      • 9.4.6.3. France: Mycoplasma Testing Market, by Application, 2019-2032 (USD Million)
      • 9.4.6.4. France: Mycoplasma Testing Market, by Technique, 2019-2032 (USD Million)
    • 9.4.7. Mycoplasma Testing Market - Germany
      • 9.4.7.1. Germany: Mycoplasma Testing Market, by Product & Service, 2019-2032 (USD Million)
      • 9.4.7.2. Germany: Mycoplasma Testing Market, by End User, 2019-2032 (USD Million)
      • 9.4.7.3. Germany: Mycoplasma Testing Market, by Application, 2019-2032 (USD Million)
      • 9.4.7.4. Germany: Mycoplasma Testing Market, by Technique, 2019-2032 (USD Million)
    • 9.4.8. Mycoplasma Testing Market - Italy
      • 9.4.8.1. Italy: Mycoplasma Testing Market, by Product & Service, 2019-2032 (USD Million)
      • 9.4.8.2. Italy: Mycoplasma Testing Market, by End User, 2019-2032 (USD Million)
      • 9.4.8.3. Italy: Mycoplasma Testing Market, by Application, 2019-2032 (USD Million)
      • 9.4.8.4. Italy: Mycoplasma Testing Market, by Technique, 2019-2032 (USD Million)
    • 9.4.9. Mycoplasma Testing Market - Spain
      • 9.4.9.1. Spain: Mycoplasma Testing Market, by Product & Service, 2019-2032 (USD Million)
      • 9.4.9.2. Spain: Mycoplasma Testing Market, by End User, 2019-2032 (USD Million)
      • 9.4.9.3. Spain: Mycoplasma Testing Market, by Application, 2019-2032 (USD Million)
      • 9.4.9.4. Spain: Mycoplasma Testing Market, by Technique, 2019-2032 (USD Million)
    • 9.4.10. Mycoplasma Testing Market - Netherlands
      • 9.4.10.1. Netherlands: Mycoplasma Testing Market, by Product & Service, 2019-2032 (USD Million)
      • 9.4.10.2. Netherlands: Mycoplasma Testing Market, by End User, 2019-2032 (USD Million)
      • 9.4.10.3. Netherlands: Mycoplasma Testing Market, by Application, 2019-2032 (USD Million)
      • 9.4.10.4. Netherlands: Mycoplasma Testing Market, by Technique, 2019-2032 (USD Million)
    • 9.4.11. Mycoplasma Testing Market - Russia
      • 9.4.11.1. Russia: Mycoplasma Testing Market, by Product & Service, 2019-2032 (USD Million)
      • 9.4.11.2. Russia.: Mycoplasma Testing Market, by End User, 2019-2032 (USD Million)
      • 9.4.11.3. Russia: Mycoplasma Testing Market, by Application, 2019-2032 (USD Million)
      • 9.4.11.4. Russia: Mycoplasma Testing Market, by Technique, 2019-2032 (USD Million)
  • 9.5. Mycoplasma Testing Market - Asia Pacific
    • 9.5.1. Asia Pacific: Mycoplasma Testing Market, by Product & Service, 2019-2032 (USD Million)
    • 9.5.2. Asia Pacific: Mycoplasma Testing Market, by End User, 2019-2032 (USD Million)
    • 9.5.3. Asia Pacific: Mycoplasma Testing Market, by Application, 2019-2032 (USD Million)
    • 9.5.4. Asia Pacific: Mycoplasma Testing Market, by Technique, 2019-2032 (USD Million)
    • 9.5.5. Mycoplasma Testing Market - China
      • 9.5.5.1. China: Mycoplasma Testing Market, by Product & Service, 2019-2032 (USD Million)
      • 9.5.5.2. China.: Mycoplasma Testing Market, by End User, 2019-2032 (USD Million)
      • 9.5.5.3. China: Mycoplasma Testing Market, by Application, 2019-2032 (USD Million)
      • 9.5.5.4. China: Mycoplasma Testing Market, by Technique, 2019-2032 (USD Million)
    • 9.5.6. Mycoplasma Testing Market - India
      • 9.5.6.1. India: Mycoplasma Testing Market, by Product & Service, 2019-2032 (USD Million)
      • 9.5.6.2. India.: Mycoplasma Testing Market, by End User, 2019-2032 (USD Million)
      • 9.5.6.3. India: Mycoplasma Testing Market, by Application, 2019-2032 (USD Million)
      • 9.5.6.4. India: Mycoplasma Testing Market, by Technique, 2019-2032 (USD Million)
    • 9.5.7. Mycoplasma Testing Market - Japan
      • 9.5.7.1. Japan: Mycoplasma Testing Market, by Product & Service, 2019-2032 (USD Million)
      • 9.5.7.2. Japan.: Mycoplasma Testing Market, by End User, 2019-2032 (USD Million)
      • 9.5.7.3. Japan: Mycoplasma Testing Market, by Application, 2019-2032 (USD Million)
      • 9.5.7.4. Japan: Mycoplasma Testing Market, by Technique, 2019-2032 (USD Million)
    • 9.5.8. Mycoplasma Testing Market - Malaysia
      • 9.5.8.1. Malaysia: Mycoplasma Testing Market, by Product & Service, 2019-2032 (USD Million)
      • 9.5.8.2. Malaysia.: Mycoplasma Testing Market, by End User, 2019-2032 (USD Million)
      • 9.5.8.3. Malaysia: Mycoplasma Testing Market, by Application, 2019-2032 (USD Million)
      • 9.5.8.4. Malaysia: Mycoplasma Testing Market, by Technique, 2019-2032 (USD Million)
    • 9.5.9. Mycoplasma Testing Market - Indonesia
      • 9.5.9.1. Indonesia: Mycoplasma Testing Market, by Product & Service, 2019-2032 (USD Million)
      • 9.5.9.2. Indonesia.: Mycoplasma Testing Market, by End User, 2019-2032 (USD Million)
      • 9.5.9.3. Indonesia: Mycoplasma Testing Market, by Application, 2019-2032 (USD Million)
      • 9.5.9.4. Indonesia: Mycoplasma Testing Market, by Technique, 2019-2032 (USD Million)
    • 9.5.10. Mycoplasma Testing Market - South Korea
      • 9.5.10.1. South Korea: Mycoplasma Testing Market, by Product & Service, 2019-2032 (USD Million)
      • 9.5.10.2. South Korea.: Mycoplasma Testing Market, by End User, 2019-2032 (USD Million)
      • 9.5.10.3. South Korea: Mycoplasma Testing Market, by Application, 2019-2032 (USD Million)
      • 9.5.10.4. South Korea: Mycoplasma Testing Market, by Technique, 2019-2032 (USD Million)
  • 9.6. Mycoplasma Testing Market - Middle East & Africa
    • 9.6.1. Middle East & Africa: Mycoplasma Testing Market, by Product & Service, 2019-2032 (USD Million)
    • 9.6.2. Middle East & Africa: Mycoplasma Testing Market, by End User, 2019-2032 (USD Million)
    • 9.6.3. Middle East & Africa: Mycoplasma Testing Market, by Application, 2019-2032 (USD Million)
    • 9.6.4. Middle East & Africa: Mycoplasma Testing Market, by Technique, 2019-2032 (USD Million)
    • 9.6.5. Mycoplasma Testing Market - Saudi Arabia
      • 9.6.5.1. Saudi Arabia: Mycoplasma Testing Market, by Product & Service, 2019-2032 (USD Million)
      • 9.6.5.2. Saudi Arabia: Mycoplasma Testing Market, by End User, 2019-2032 (USD Million)
      • 9.6.5.3. Saudi Arabia: Mycoplasma Testing Market, by Application, 2019-2032 (USD Million)
      • 9.6.5.4. Saudi Arabia: Mycoplasma Testing Market, by Technique, 2019-2032 (USD Million)
    • 9.6.6. Mycoplasma Testing Market - South Africa
      • 9.6.6.1. South Africa: Mycoplasma Testing Market, by Product & Service, 2019-2032 (USD Million)
      • 9.6.6.2. South Africa: Mycoplasma Testing Market, by End User, 2019-2032 (USD Million)
      • 9.6.6.3. South Africa: Mycoplasma Testing Market, by Application, 2019-2032 (USD Million)
      • 9.6.6.4. South Africa: Mycoplasma Testing Market, by Technique, 2019-2032 (USD Million)
    • 9.6.7. Mycoplasma Testing Market - Israel
      • 9.6.7.1. Israel: Mycoplasma Testing Market, by Product & Service, 2019-2032 (USD Million)
      • 9.6.7.2. Israel: Mycoplasma Testing Market, by End User, 2019-2032 (USD Million)
      • 9.6.7.3. Israel: Mycoplasma Testing Market, by Application, 2019-2032 (USD Million)
      • 9.6.7.4. Israel: Mycoplasma Testing Market, by Technique, 2019-2032 (USD Million)
    • 9.6.8. Mycoplasma Testing Market - UAE
      • 9.6.8.1. UAE: Mycoplasma Testing Market, by Product & Service, 2019-2032 (USD Million)
      • 9.6.8.2. UAE: Mycoplasma Testing Market, by End User, 2019-2032 (USD Million)
      • 9.6.8.3. UAE: Mycoplasma Testing Market, by Application, 2019-2032 (USD Million)
      • 9.6.8.4. UAE: Mycoplasma Testing Market, by Technique, 2019-2032 (USD Million)
  • 9.7. Mycoplasma Testing Market - Latin America
    • 9.7.1. Latin America: Mycoplasma Testing Market, by Product & Service, 2019-2032 (USD Million)
    • 9.7.2. Latin America: Mycoplasma Testing Market, by End User, 2019-2032 (USD Million)
    • 9.7.3. Latin America: Mycoplasma Testing Market, by Application, 2019-2032 (USD Million)
    • 9.7.4. Latin America: Mycoplasma Testing Market, by Technique, 2019-2032 (USD Million)
    • 9.7.5. Mycoplasma Testing Market - Mexico
      • 9.7.5.1. Mexico: Mycoplasma Testing Market, by Product & Service, 2019-2032 (USD Million)
      • 9.7.5.2. Mexico: Mycoplasma Testing Market, by End User, 2019-2032 (USD Million)
      • 9.7.5.3. Mexico: Mycoplasma Testing Market, by Application, 2019-2032 (USD Million)
      • 9.7.5.4. Mexico: Mycoplasma Testing Market, by Technique, 2019-2032 (USD Million)
    • 9.7.6. Mycoplasma Testing Market - Brazil
      • 9.7.6.1. Brazil: Mycoplasma Testing Market, by Product & Service, 2019-2032 (USD Million)
      • 9.7.6.2. Brazil: Mycoplasma Testing Market, by End User, 2019-2032 (USD Million)
      • 9.7.6.3. Brazil: Mycoplasma Testing Market, by Application, 2019-2032 (USD Million)
      • 9.7.6.4. Brazil: Mycoplasma Testing Market, by Technique, 2019-2032 (USD Million)
    • 9.7.7. Mycoplasma Testing Market - Argentina
      • 9.7.7.1. Argentina: Mycoplasma Testing Market, by Product & Service, 2019-2032 (USD Million)
      • 9.7.7.2. Argentina: Mycoplasma Testing Market, by End User, 2019-2032 (USD Million)
      • 9.7.7.3. Argentina: Mycoplasma Testing Market, by Application, 2019-2032 (USD Million)
      • 9.7.7.4. Argentina: Mycoplasma Testing Market, by Technique, 2019-2032 (USD Million)

10. Competitive Landscape

  • 10.1. Expansion and Acquisition Analysis
    • 10.1.1. Expansion
    • 10.1.2. Acquisitions
  • 10.2. Partnerships/Collaborations/Agreements/Exhibitions

11. Company Profiles

  • 11.1. Agilent Technologies (US)
    • 11.1.1. Company Overview
    • 11.1.2. Financial Performance
    • 11.1.3. Product Benchmarking
    • 11.1.4. Recent Development
  • 11.2. American Type Culture Collection (US)
    • 11.2.1. Company Overview
    • 11.2.2. Financial Performance
    • 11.2.3. Product Benchmarking
    • 11.2.4. Recent Development
  • 11.3. Biological Industries Israel Beit Haemek Ltd. (Israel)
    • 11.3.1. Company Overview
    • 11.3.2. Financial Performance
    • 11.3.3. Product Benchmarking
    • 11.3.4. Recent Development
  • 11.4. Bionique Testing Laboratories, Inc. (US)
    • 11.4.1. Company Overview
    • 11.4.2. Financial Performance
    • 11.4.3. Product Benchmarking
    • 11.4.4. Recent Development
  • 11.5. Biotools B & M Labs, S.A. (Spain)
    • 11.5.1. Company Overview
    • 11.5.2. Financial Performance
    • 11.5.3. Product Benchmarking
    • 11.5.4. Recent Development
  • 11.6. Charles River Laboratories International, Inc. (US)
    • 11.6.1. Company Overview
    • 11.6.2. Financial Performance
    • 11.6.3. Product Benchmarking
    • 11.6.4. Recent Development
  • 11.7. Creative Bioarray (US)
    • 11.7.1. Company Overview
    • 11.7.2. Financial Performance
    • 11.7.3. Product Benchmarking
    • 11.7.4. Recent Development
  • 11.8. Eurofins Scientific (Luxembourg)
    • 11.8.1. Company Overview
    • 11.8.2. Financial Performance
    • 11.8.3. Product Benchmarking
    • 11.8.4. Recent Development
  • 11.9. GeneCopoeia, Inc. (US)
    • 11.9.1. Company Overview
    • 11.9.2. Financial Performance
    • 11.9.3. Product Benchmarking
    • 11.9.4. Recent Development
  • 11.10. GenBio (Canada)
    • 11.10.1. Company Overview
    • 11.10.2. Financial Performance
    • 11.10.3. Product Benchmarking
    • 11.10.4. Recent Development
  • 11.11. InvivoGen (US)
    • 11.11.1. Company Overview
    • 11.11.2. Financial Performance
    • 11.11.3. Product Benchmarking
    • 11.11.4. Recent Development
  • 11.12. Lonza Group Ltd. (Switzerland)
    • 11.12.1. Company Overview
    • 11.12.2. Financial Performance
    • 11.12.3. Product Benchmarking
    • 11.12.4. Recent Development
  • 11.13. Merck KGaA (Germany)
    • 11.13.1. Company Overview
    • 11.13.2. Financial Performance
    • 11.13.3. Product Benchmarking
    • 11.13.4. Recent Development
  • 11.14. Meridian Bioscience, Inc. (US)
    • 11.14.1. Company Overview
    • 11.14.2. Financial Performance
    • 11.14.3. Product Benchmarking
    • 11.14.4. Recent Development
  • 11.15. Minerva Biolabs GmbH (Germany)
    • 11.15.1. Company Overview
    • 11.15.2. Financial Performance
    • 11.15.3. Product Benchmarking
    • 11.15.4. Recent Development

List of Tables

  • Table 1 Global Mycoplasma Testing Market, by Product & Service, by Region, 2019-2032 (USD Million)
  • Table 2 Global Mycoplasma Testing Market, by Application, by Region, 2019-2032 (USD Million)
  • Table 3 Global Mycoplasma Testing Market, by Technique, by Region, 2019-2032 (USD Million)
  • Table 4 Global Mycoplasma Testing Market, by End User, by Region, 2019-2032 (USD Million)
  • Table 5 Mycoplasma Testing Market Assessment, By Geography, 2019-2032 (USD Million)
  • Table 6 North America: Mycoplasma Testing Market, by Product & Service, 2019-2032 (USD Million)
  • Table 7 North America: Mycoplasma Testing Market, by Application, 2019-2032 (USD Million)
  • Table 8 North America: Mycoplasma Testing Market, by Technique, 2019-2032 (USD Million)
  • Table 9 North America: Mycoplasma Testing Market, by End User, 2019-2032 (USD Million)
  • Table 10 U.S.: Mycoplasma Testing Market, by Product & Service, 2019-2032 (USD Million)
  • Table 11 U.S.: Mycoplasma Testing Market, by Application, 2019-2032 (USD Million)
  • Table 12 U.S.: Mycoplasma Testing Market, by Technique, 2019-2032 (USD Million)
  • Table 13 U.S.: Mycoplasma Testing Market, by End User, 2019-2032 (USD Million)
  • Table 14 Canada: Mycoplasma Testing Market, by Product & Service, 2019-2032 (USD Million)
  • Table 15 Canada: Mycoplasma Testing Market, by Application, 2019-2032 (USD Million)
  • Table 16 Canada: Mycoplasma Testing Market, by Technique, 2019-2032 (USD Million)
  • Table 17 Canada: Mycoplasma Testing Market, by End User, 2019-2032 (USD Million)
  • Table 18 Europe: Mycoplasma Testing Market, by Product & Service, 2019-2032 (USD Million)
  • Table 19 Europe: Mycoplasma Testing Market, by Application, 2019-2032 (USD Million)
  • Table 20 Europe: Mycoplasma Testing Market, by Technique, 2019-2032 (USD Million)
  • Table 21 Europe: Mycoplasma Testing Market, by End User, 2019-2032 (USD Million)
  • Table 22 Germany: Mycoplasma Testing Market, by Product & Service, 2019-2032 (USD Million)
  • Table 23 Germany: Mycoplasma Testing Market, by Application, 2019-2032 (USD Million)
  • Table 24 Germany: Mycoplasma Testing Market, by Technique, 2019-2032 (USD Million)
  • Table 25 Germany: Mycoplasma Testing Market, by End User, 2019-2032 (USD Million)
  • Table 26 France: Mycoplasma Testing Market, by Product & Service, 2019-2032 (USD Million)
  • Table 27 France: Mycoplasma Testing Market, by Application, 2019-2032 (USD Million)
  • Table 28 France: Mycoplasma Testing Market, by Technique, 2019-2032 (USD Million)
  • Table 29 France: Mycoplasma Testing Market, by End User, 2019-2032 (USD Million)
  • Table 30 UK: Mycoplasma Testing Market, by Product & Service, 2019-2032 (USD Million)
  • Table 31 UK: Mycoplasma Testing Market, by Application, 2019-2032 (USD Million)
  • Table 32 UK: Mycoplasma Testing Market, by Technique, 2019-2032 (USD Million)
  • Table 33 UK: Mycoplasma Testing Market, by End User, 2019-2032 (USD Million)
  • Table 34 Italy: Mycoplasma Testing Market, by Product & Service, 2019-2032 (USD Million)
  • Table 35 Italy: Mycoplasma Testing Market, by Application, 2019-2032 (USD Million)
  • Table 36 Italy: Mycoplasma Testing Market, by Technique, 2019-2032 (USD Million)
  • Table 37 Italy: Mycoplasma Testing Market, by End User, 2019-2032 (USD Million)
  • Table 38 Netherlands: Mycoplasma Testing Market, by Product & Service, 2019-2032 (USD Million)
  • Table 39 Netherlands: Mycoplasma Testing Market, by Application, 2019-2032 (USD Million)
  • Table 40 Netherlands: Mycoplasma Testing Market, by Technique, 2019-2032 (USD Million)
  • Table 41 Netherlands: Mycoplasma Testing Market, by End User, 2019-2032 (USD Million)
  • Table 42 Spain: Mycoplasma Testing Market, by Product & Service, 2019-2032 (USD Million)
  • Table 43 Spain: Mycoplasma Testing Market, by Application, 2019-2032 (USD Million)
  • Table 44 Spain: Mycoplasma Testing Market, by Technique, 2019-2032 (USD Million)
  • Table 45 Spain: Mycoplasma Testing Market, by End User, 2019-2032 (USD Million)
  • Table 46 Russia: Mycoplasma Testing Market, by Product & Service, 2019-2032 (USD Million)
  • Table 47 Russia: Mycoplasma Testing Market, by Application, 2019-2032 (USD Million)
  • Table 48 Russia: Mycoplasma Testing Market, by Technique, 2019-2032 (USD Million)
  • Table 49 Russia: Mycoplasma Testing Market, by End User, 2019-2032 (USD Million)
  • Table 50 Asia Pacific: Mycoplasma Testing Market, by Product & Service, 2019-2032 (USD Million)
  • Table 51 Asia Pacific: Mycoplasma Testing Market, by Application, 2019-2032 (USD Million)
  • Table 52 Asia Pacific: Mycoplasma Testing Market, by Technique, 2019-2032 (USD Million)
  • Table 53 Asia Pacific: Mycoplasma Testing Market, by End User, 2019-2032 (USD Million)
  • Table 54 China: Mycoplasma Testing Market, by Product & Service, 2019-2032 (USD Million)
  • Table 55 China: Mycoplasma Testing Market, by Application, 2019-2032 (USD Million)
  • Table 56 China: Mycoplasma Testing Market, by Technique, 2019-2032 (USD Million)
  • Table 57 China: Mycoplasma Testing Market, by End User, 2019-2032 (USD Million)
  • Table 58 Japan: Mycoplasma Testing Market, by Product & Service, 2019-2032 (USD Million)
  • Table 59 Japan: Mycoplasma Testing Market, by Application, 2019-2032 (USD Million)
  • Table 60 Japan: Mycoplasma Testing Market, by Technique, 2019-2032 (USD Million)
  • Table 61 Japan: Mycoplasma Testing Market, by End User, 2019-2032 (USD Million)
  • Table 62 India: Mycoplasma Testing Market, by Product & Service, 2019-2032 (USD Million)
  • Table 63 India: Mycoplasma Testing Market, by Application, 2019-2032 (USD Million)
  • Table 64 India: Mycoplasma Testing Market, by Technique, 2019-2032 (USD Million)
  • Table 65 India: Mycoplasma Testing Market, by End User, 2019-2032 (USD Million)
  • Table 66 Indonesia: Mycoplasma Testing Market, by Product & Service, 2019-2032 (USD Million)
  • Table 67 Indonesia: Mycoplasma Testing Market, by Application, 2019-2032 (USD Million)
  • Table 68 Indonesia: Mycoplasma Testing Market, by Technique, 2019-2032 (USD Million)
  • Table 69 Indonesia: Mycoplasma Testing Market, by End User, 2019-2032 (USD Million)
  • Table 70 Malaysia: Mycoplasma Testing Market, by Product & Service, 2019-2032 (USD Million)
  • Table 71 Malaysia: Mycoplasma Testing Market, by Application, 2019-2032 (USD Million)
  • Table 72 Malaysia: Mycoplasma Testing Market, by Technique, 2019-2032 (USD Million)
  • Table 73 Malaysia: Mycoplasma Testing Market, by End User, 2019-2032 (USD Million)
  • Table 74 South Korea: Mycoplasma Testing Market, by Product & Service, 2019-2032 (USD Million)
  • Table 75 South Korea: Mycoplasma Testing Market, by Application, 2019-2032 (USD Million)
  • Table 76 South Korea: Mycoplasma Testing Market, by Technique, 2019-2032 (USD Million)
  • Table 77 South Korea: Mycoplasma Testing Market, by End User, 2019-2032 (USD Million)
  • Table 78 Latin America: Mycoplasma Testing Market, by Product & Service, 2019-2032 (USD Million)
  • Table 79 Latin America: Mycoplasma Testing Market, by Application, 2019-2032 (USD Million)
  • Table 80 Latin America: Mycoplasma Testing Market, by Technique, 2019-2032 (USD Million)
  • Table 81 Latin America: Mycoplasma Testing Market, by End User, 2019-2032 (USD Million)
  • Table 82 Brazil: Mycoplasma Testing Market, by Product & Service, 2019-2032 (USD Million)
  • Table 83 Brazil: Mycoplasma Testing Market, by Application, 2019-2032 (USD Million)
  • Table 84 Brazil: Mycoplasma Testing Market, by Technique, 2019-2032 (USD Million)
  • Table 85 Brazil: Mycoplasma Testing Market, by End User, 2019-2032 (USD Million)
  • Table 86 Mexico: Mycoplasma Testing Market, by Product & Service, 2019-2032 (USD Million)
  • Table 87 Mexico: Mycoplasma Testing Market, by Application, 2019-2032 (USD Million)
  • Table 88 Mexico: Mycoplasma Testing Market, by Technique, 2019-2032 (USD Million)
  • Table 89 Mexico: Mycoplasma Testing Market, by End User, 2019-2032 (USD Million)
  • Table 90 Argentina: Mycoplasma Testing Market, by Product & Service, 2019-2032 (USD Million)
  • Table 91 Argentina: Mycoplasma Testing Market, by Application, 2019-2032 (USD Million)
  • Table 92 Argentina: Mycoplasma Testing Market, by Technique, 2019-2032 (USD Million)
  • Table 93 Argentina: Mycoplasma Testing Market, by End User, 2019-2032 (USD Million)
  • Table 94 Middle East & Africa: Mycoplasma Testing Market, by Product & Service, 2019-2032 (USD Million)
  • Table 95 Middle East & Africa: Mycoplasma Testing Market, by Application, 2019-2032 (USD Million)
  • Table 96 Middle East & Africa: Mycoplasma Testing Market, by Technique, 2019-2032 (USD Million)
  • Table 97 Middle East & Africa: Mycoplasma Testing Market, by End User, 2019-2032 (USD Million)
  • Table 98 UAE: Mycoplasma Testing Market, by Product & Service, 2019-2032 (USD Million)
  • Table 99 UAE: Mycoplasma Testing Market, by Application, 2019-2032 (USD Million)
  • Table 100 UAE: Mycoplasma Testing Market, by Technique, 2019-2032 (USD Million)
  • Table 101 UAE: Mycoplasma Testing Market, by End User, 2019-2032 (USD Million)
  • Table 102 Saudi Arabia: Mycoplasma Testing Market, by Product & Service, 2019-2032 (USD Million)
  • Table 103 Saudi Arabia: Mycoplasma Testing Market, by Application, 2019-2032 (USD Million)
  • Table 104 Saudi Arabia: Mycoplasma Testing Market, by Technique, 2019-2032 (USD Million)
  • Table 105 Saudi Arabia: Mycoplasma Testing Market, by End User, 2019-2032 (USD Million)
  • Table 106 South Africa: Mycoplasma Testing Market, by Product & Service, 2019-2032 (USD Million)
  • Table 107 South Africa: Mycoplasma Testing Market, by Application, 2019-2032 (USD Million)
  • Table 108 South Africa: Mycoplasma Testing Market, by Technique, 2019-2032 (USD Million)
  • Table 109 South Africa: Mycoplasma Testing Market, by End User, 2019-2032 (USD Million)
  • Table 110 Israel: Mycoplasma Testing Market, by Product & Service, 2019-2032 (USD Million)
  • Table 111 Israel: Mycoplasma Testing Market, by Application, 2019-2032 (USD Million)
  • Table 112 Israel: Mycoplasma Testing Market, by Technique, 2019-2032 (USD Million)
  • Table 113 Israel: Mycoplasma Testing Market, by End User, 2019-2032 (USD Million)

List of Figures

  • Figure 1. Global Mycoplasma Testing Market, 2019-2032 (USD Million)
  • Figure 2. Integrated Ecosystem
  • Figure 3. Research Methodology: Top-Down & Bottom-Up End User
  • Figure 4. Market by Geography
  • Figure 5. Porter's Five Forces
  • Figure 6. Market by Product & Service
  • Figure 7. Global Mycoplasma Testing Market, by Product & Service, 2021 & 2030 (USD Million)
  • Figure 8. Market by End User
  • Figure 9. Global Mycoplasma Testing Market, by End User, 2021 & 2030 (USD Million)
  • Figure 10. Market by Application
  • Figure 11. Global Mycoplasma Testing Market, by Application, 2021 & 2030 (USD Million)
  • Figure 12. Market by Technique
  • Figure 13. Global Mycoplasma Testing Market, by Technique, 2021 & 2030 (USD Million)